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I enjoy reading book reviews, but I don't like writing them. The reasons for the latter are self evident, in that one is morally obliged to read the book almost from cover to cover if one is going to review it and sometimes this can be a tremendous ordeal and with certain books, extremely boring. I had no problems with the ABC of Breast Diseases because I had read many of the parts that made up this book when they appeared originally in the British Medical Journal and I also was one of the contributors to the section on clinical trials. The book is beautifully set out and lavishly illustrated, and therefore an ideal companion for the general practitioner in his surgery or the young clinical specialist struggling to cope with an overbooked breast clinic.
I hope I can encourage you to enjoy reading this review for the same reasons I enjoy reading book reviews -namely, that they tell you as much about the reviewer as the book itself. For example, over the last weekend I was reading the Sunday Times supplement and came across a book concerned with the new mathematics necessary for the understanding of complex biological systems. This subject is of great interest to me (vide infra), but clearly disturbed the reviewer. Whoever wrote the review must have been some kind of mystic who resented the fact that science was trying to encroach into the complexities of nature which should be protected from scientific scrutiny. The reviewer also seemed to resent any study of the mind as this encroached upon the study of the soul! I am certainly no mystic, but I happen to believe we need a new understanding of the complex biological system which we describe as carcinoma of the breast. The behaviour of this disease is largely unpredictable and those mathematical models that attempt to predict are inconsistent with some of our cherished beliefs of the growth and spread of the disease. This obliquely brings me round to the main subject of the review and of this journal which is the section on screening.
The fundamental belief governing this approach is that the primary cancer grows at a set rate according to the mathematics oflinear equations, seeding distant metastases according to stochastic rules and these metastases continue to grow at the same rate as the primary. It is believed that there is a window of opportunity between the mammographically detected tumour and the clinically detected tumour when a significant number of breast cancers can be identified and removed before they have had an opportunity to spread. So attractive is this model that many screening zealots round the world have run ahead of the available evidence from clinical trials to offer screening to women of all ages.
The chapter in this book does set the record straight as far as that is concerned, and certainly makes no extravagant claims for mammographic screening programmes and is excellent in describing the methodology from detection to biopsy, but fails to emphasise the controversies that are still being debated within the scientific community. For example, as with all publications on screening, the benefits are described as relative risk reductions in cause specific mortality. No attempt is ever made to translate this into absolute benefits for the individual woman, nor are there harm benefit analyses described.
In fact the opening sentence and the accompanying bullet point is simply wrong. The authors of this section, Blamey, Wilson, and Patnick start off by saying that primary prevention is a distant prospect and this is followed by a bullet point in a box which states that the aim of screening is to detect breast cancer when it is small and before it has had a chance to spread. I would have thought that the aim of screening was to stop women dying of breast cancer. Furthermore, we are well advanced with trials of primary prevention using tamoxifen for high risk groups.
Next, they are guilty of the statistical solecism of claiming up to 40% reduction in breast cancer mortality among those women who attend for screening. This ignores the fact that "attendees" are a select group who have a lower mortality from all diseases compared with women who do not accept public health interventions.
The authors are also very good at emphasising the surrogate end points within the NHS programme, constantly losing sight of the real end point of an overall reduction in breast cancer mortality. Of course screen detected cancers have a longer survival rate and of course they have better pathological features, but these two facts could be explained by the lead time, which might be two to three years for screen detected cancers, and also the fact that screening is good at picking up good cancer, whereas the cancers that are most likely to kill the women are the ones that pop up at intervals (conspicuous by its absence is any mention of the disturbing interval cancer rates that have already been published within the NHS breast screening programme).
They also dismiss the risk of overdiagnosis, yet fail to point out that 17% of the screen detected carcinomata are duct carcinoma in situ and that postmortem studies of women dying from unrelated disease would suggest that only one in four or one in five of these would progress to invasive disease in the woman's lifetime (the analogous situation to that seen with elderly men and in situ prostatic cancer). The authors are also dismissive of the proponents of two view mammography and it's a pity that this piece was written before the results of the United Kingdom Coordinating Committee on Cancer Research trial that was recently published in the British Medical Journal. I Two view mammograms are now shown to reduce the recall rate by about 15% and increase the detection rate by 24%. In other words, this will, to a small extent, redress the balance of harm versus benefit for the individual woman called for screening.
This brings me to my final criticism of this chapter and the screening programme in its entirety and this concerns the double standards of informed consent. If! wish to operate on a woman I am expected to provide her with all the information she needs to make a rational decision. Yet for the screening programme to achieve its 70% compliance rate within the target population, it is necessary 233 to be economical with the truth. Mammography is marketed as if it was an intervention of undiluted benefit. I believe if women knew the full truth concerning the false alarms, the unnecessary surgery, the diagnosis of borderline pathology, the risk of overtreatment, and the problems they might have with life insurance and mortgage applications, they might consider that the absolute benefit (less than 1% reduction in the risk of dying of breast cancer over a 10 year period of screening) not sufficient. The 70% compliance necessary to justify the programme would then not be achieved. The promotion of screening has led to a very high level of anxiety about breast cancer in our community. To maintain a high acceptance rate for screening it is necessary constantly to re-engineer this level of anxiety. The woman, her cancer, and her putative metastases is a complex system easily perturbed. As a self appointed defender of this wonderful organism I will continue to perturb the screening establishment in return. It is always interesting to compare screening programmes in different countries, partly because it prevents a complacent or arrogant view from developing about what exists in one's own country and, secondly, the process can be enlightening in terms of describing differences in philosophical outlook or of offering alternative models of care. This book certainly maintains the reader's interest in both these aspects.
The report is the Dutch equivalent of the Hall report on preschool child health surveillance in the United Kingdom. Both books were written by multidisciplinary working parties following extensive literature reviews of the subject. However, there are a number of important differences. The Dutch working party included experts from the social science disciplines, advisory bodies, medical insurance companies, and parents' associations in addition to the health professionals. There is greater emphasis placed on cost effectiveness and its measurement for different parts of the programme in Holland.
The book is clearly laid out with a focus on four principal themes. The first section covers the aims, procedures, and outcomes of preschool child health care. The definition of the aim is holistic and makes reference to parental responsibility, environmental factors and the importance of the system of care itself in promoting child health. The working party recognises the difficulties in measurement of outcome of preschool child health care that
